...
首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >A quantitative treatment planning study evaluating the potential of dose escalation in conformal radiotherapy of the oesophagus.
【24h】

A quantitative treatment planning study evaluating the potential of dose escalation in conformal radiotherapy of the oesophagus.

机译:定量治疗计划研究评估了食管适形放疗中剂量递增的潜力。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND PURPOSE: This study aims to evaluate the reduction in radiation dose to normal thoracic structures through the use of conformal radiotherapy techniques in the treatment of oesophageal cancer, and to quantify the resultant potential for dose escalation. MATERIALS AND METHODS: Three different CT-derived treatment plans were created and compared for each of ten patients. A two-phase treatment with conventional straight-edged fields and standard blocks (CV2), a two-phase conformal plan (CF2), and a three-phase conformal plan where the third phase was delivered to the gross tumour only (CF3), were considered for each patient. Escalated dose levels were determined for techniques CF2 and CF3, which by virtue of the conformal field shaping, did not increase the mean lung dose. The resulting increase in tumour control probability (TCP) was estimated. RESULTS: A two-phase conformal technique (CF2) reduced the volume of lung irradiated to 18 Gy from 19.7+/-11.8 (1 SD) to 17.1+/-12.3% (P=0.004), and reduced the normal tissue complication probability (NTCP) from 2.4+/-4.0 to 0.7+/-1.6% (P=0.02) for a standard prescribed dose of 55 Gy. Consequently, technique CF2 permitted a target dose of 59.1+/-3.2 Gy without increasing the mean lung dose. Technique CF3 facilitated a prescribed dose of 60.7+/-4.3 Gy to the target, the additional 5 Gy increasing the TCP from 53. 1+/-5.5 to 68.9+/-4.1%. When the spinal cord tolerance was raised from 45 to 48 Gy, technique CF3 allowed 63.6+/-4.l Gy to be delivered to the target, thereby increasing the TCP to 78.1+/-3.2%. CONCLUSIONS: Conformal radiotherapy techniques offer the potential for a 5-10 Gy escalation in dose delivered to the oesophagus, without increasing the mean lung dose. This is expected to increase local tumour control by 15-25%.
机译:背景与目的:本研究旨在通过使用保形放射疗法技术治疗食道癌来评估对正常胸腔结构的放射剂量减少,并量化由此产生的剂量递增潜力。材料与方法:创建了三种不同的CT衍生治疗计划,并对十名患者中的每位进行了比较。使用常规直边视野和标准块(CV2)进行两阶段治疗,采用两阶段适形计划(CF2),以及将第三阶段仅递送至大体肿瘤(CF3)的三相适形计划,被考虑为每个患者。确定了CF2和CF3技术的剂量递增水平,由于采用了共形场成形技术,因此不会增加平均肺部剂量。估计肿瘤控制概率(TCP)的增加。结果:两相适形技术(CF2)将辐照至18 Gy的肺体积从19.7 +/- 11.8(1 SD)降低到17.1 +/- 12.3%(P = 0.004),并降低了正常组织并发症的可能性(55)的标准处方剂量(NTCP)从2.4 +/- 4.0降至0.7 +/- 1.6%(P = 0.02)。因此,技术CF2允许59.1 +/- 3.2 Gy的目标剂量而不增加平均肺部剂量。技术CF3促进了对靶标的60.7 +/- 4.3 Gy的处方剂量,另外的5 Gy使TCP从53. 1 +/- 5.5增加到68.9 +/- 4.1%。当脊髓耐受性从45 Gy提高到48 Gy时,技术CF3允许将63.6 +/- 4.1 Gy递送至靶标,从而将TCP增至78.1 +/- 3.2%。结论:适形放疗技术可将食管的剂量增加5-10 Gy,而不会增加平均肺部剂量。预期这将使局部肿瘤控制提高15-25%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号